Jump to content

AbbVie drops IBS drug Viberzi in Canada, 'devastating' patients - Endpoints News


Recommended Posts

Scoop: AbbVie drops IBS drug Viberzi in Canada, 'devastating' patients  Endpoints News

AbbVie has since confirmed to Endpoints that it is discontinuing Viberzi in Canada this year “as a result of our regular business prioritization review.” The drug will continue to be available in the US, as well as the UK — where Sam lives —  with “no plans to discontinue,” a spokesperson said. It had already been discontinued in the EU back in 2020 at the request of Allergan, the drug’s initial manufacturer before the $63 billion AbbVie buyout that year.

The pharma company declined to offer further explanation of its reasoning behind the discontinuation, adding that there “are alternative therapies available for patients.”

View the full article


Link to post
Share on other sites

  • 4 months later...
Jeffrey Roberts

Update:

Allergan Canada and/or Abbvie are considering providing continued access to Viberzi in Canada due to the number of calls that patients have been making to the Allergan Customer Care center.

Patients can contact them 800-668-6424 or MR-GENERAL_INQUIRY@allergan.com

Link to post
Share on other sites

  • Jeffrey Roberts changed the title to AbbVie drops IBS drug Viberzi in Canada, 'devastating' patients - Endpoints News

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

 Share

×
×
  • Create New...